Member Info for MisterPositive

Love the tea lady banter...LoL

May be this tea lady used to work for Petrochina before and loading up now. LoL

Doc
If i am not mistaken cost/ bbl is around $8-$10 / bbl using the trucking route to Petrochina refinery across the border. Will have to double check. Think this was in one of company presentations in London from Mike Buck few years ago when oil price was low.

That is why they said even a 15Mmbo discovery is profitable and they had some juicy NPV10 figures

Having looked at Progressive note and 58p NAV,
i am more in agreement with Hamm with 20p on LP granted as that would put MATD well and truly back on track towards their 8k - 9k bopd target over coming years.

Bigbench
@ $140/bbl NAV here should jump to around £1.16p a share.

Lockie
You should soon be in good profit with 4.70 avg.

Master...good work sir. LP is coming.

D1nger...agree on all points.

This should be back to 5.50p shortly same level as we were at before they raised $6.6m.

Good thing is we now got extra $6.6m in bank on top of plenty cash we had already.

LP being granted is big deal as that will MATD back on track towards getting to 8000-9000 bopd production target at HERON with multi-well DQE deal.

Velociraptor is a nice bonus. Success here opens up additional circa 400 million barrels with approx 600m barrels from the 3 raptors.

Agree.

58p broker target is already risk adjusted across the portfolio not just Velociraptor. Could be lot higher. Velociraptor is on proven petroleum system which not be tapped into before.

Moves fast this one. Any of the following news could come anytime. Back to back RNS may be.

1) Land permit
2) Velociraptor
3) New license/ Block(s) being added.

High Double figures easy...no brainer.

Would expect this to rise back towards 5.50p before placing hit us.

5.39p might be technical resistance on charts but could be blown away easily given the newsflow expected here.

10p would be more like temporary resistance as traders take profits before the uptrend resumes towards higher levels. IMHO.

Chart looking very good now with 31-35p very much on next week. Was very oversold after hitting almost 40p on 9th Feb - the day of NICE preliminary recommendation came.

Market is forward looking and re-rates on next 6 months events.

Yep. Lot to look forward to. This not covid stuff. We got established market for stroke. AIHL tests are first of its kind available exclusively at GDR. So Genedrive will set the tone for its own sales.

Both AIHL and stroke tests will be in high demand.
Glad to be part of the success story just starting.

Some more knowledgeable posters mentioned $80 sale price per AIHL test if i am correct.

So just 1 million tests sold would generate potential $80m revenue.

Current MCap at circa £23m does not even remotely reflect the Revenue generation upside just from AIHL tests roll out.

Good work mate on FDA 150 day count up.

Intra-day RNS today or Monday either welcome.

Think you added more fuel to the rocket.

Drop from 39.6 pence since 9 Feb was way Overdone.

Lloyd
Thanks for sharing.

Genedrive is getting ready for distribution deals in both UK and Europe by the looks before NICE report publication after they gave their prelim recommendation on 9 Feb and GDR touched just shy of 40p that Thursday (39.6p intra-day).

Agree 100%. FDA update could come any time. Its independent of NICE full report end of March. Preliminary recommendation already given for AIHL from NICE should be enough for FDA or any other Healthcare regulators in Europe and Asia Pacific.

Big bench.
Yes still in there but gone Overweight in GDR.

Big bench. Looking good. You also in GDR.

LP is frustrating.
Wish they would just get it done and move on.

Expect this back in 30s soon as Shorters scramble to get back in.

Same goes for "fence sitters" waiting to get in.
Too many eyes watching this.

Been so busy with work commitments. No time to micro-manage daily price movements. I am totally relaxed coz i am looking at the BIG PICTURE for what GDR price would be within 6-12 months and i am not talking just a £1 pound.

Shorters honeymoon period will be over soon.
50p should be minimum on formal NICE approval.
Add in FDA updat and we could fly to 80p quickly

Shorters annusses pulsating with every penny GDR goes up. They been deramping it hard.

Way OVERSOLD.

Distribution deals being lined up by the looks.

Short squeeze coming up.

£1.23 would be very low ball Takeover price given that Genedrive Plc will be bringing both AIHL tests and Stroke tests to the market in coming months one after another.

£1.23 would only value GDR at approx £113m on current 92.5m shares in issue.

We seen Biotech buy outs at 3 x times that price.

Stroke diagnostic tests market is huge. For AIHL we need some Broker analysts / research notes to get some idea of high big the AIHL tests market would be potentially. Its a global issue not just UK, Europe or USA.

At current £21m MCap this is a steal and Oversold.